18 / 21
Pathology 2018
Research & Reviews: Journal of Medical and Health Sciences
ISSN: 2319-9865
Page 50
October 08-09, 2018
Edinburgh, Scotland
17
th
International Conference on
Pathology & Cancer
Epidemiology
R
apid improvement in the DNA sequencing technologies can
revolutionize personalized genomic medicine by making
this health care approach faster and more cost-effective. The
technological revolution in high-throughput screening (HTS) and
relatively lower-cost next-generation sequencing (NGS) of DNA
influences the profound understanding of the individual genetic
makeup: these technologies predict the susceptibility to a disease
thus pave the way for therapeutics and personalized medicine.
This especially becomes of a paramount importance in pediatric
oncology. For a quicker detection of a genetic predisposition to
hereditary malignancies and any pathology at early stages allows
then to combat some of the illnesses prematurely and to avoid
ineffective and virulent therapies hence to improve the healthcare
and wellness.
Biography
Ekaterina Bazyleva was graduated from the German School in Moscow in
2014 and moved to Japan to complete her 12th year of school education.
Currently she is a student of Medical University of Varna in Bulgaria and she
is working on her PhD as a student in Department for Personalized and Pre-
cisionMedicine in University of World Politics and Law, Moscow, Russia. Her
research interest lies in the areas of Immunology, Oncology, Personalized
Medicine, Biotechnology and Artificial Intelligence.
bazekaterina24@gmail.comDNA sequencing revolution: application to pediatric oncology
Bazyleva Ekaterina Vladlenovna
1
, Sergey V Suchkov
2, 3
and
David I Smith
4
1
Medical University of Varna, Bulgaria
2
Sechenov University, Russia
3
A I Evdokimov Moscow State University of Medicine & Dentistry, Russia
4
Mayo Clinic, USA
Ekaterina Bazyleva et al., RRJMHS 2018
Volume: 7